According to a report by journalist Alex Berenson, Moderna has halted a clinical trial for a new mRNA ‘vaccine’ due to a suspected case of myocarditis in a trial participant.
“Moderna today halted dosing for adolescents in its Phase 1 clinical trial of its Epstein-Barr virus vaccine after a suspected case of myocarditis in a trial participant,” Berenson wrote Thursday.
The biotechnology company did not publicly disclose the trial halt, Berenson says.
URGENT new Unreported Truths:@moderna_tx today halted dosing for adolescents in its Phase 1 clinical trial of its Epstein-Barr virus vaccine after a suspected case of myocarditis in a trial participant.$mrna did not report the halt publicly pic.twitter.com/xgCxVcz4u2
— Alex Berenson (@AlexBerenson) November 17, 2023
*Image from Alex Berenson X post*
Moderna has a lengthy list of mRNA ‘vaccines’ up the pipe, including Epstein-Barr virus.
The clinical trial halt would surely raise awareness to the adverse health events caused by mRNA technology.
Thus, Moderna doesn’t want news of a suspected case of myocarditis from a new ‘vaccine,’ expected to generate billions in profit, to go public.
Alex Berenson…
Read the full article here
